Notes
Slide Show
Outline
1
Pediatric  Leukoencephalopathies:
  • A Neuroimaging Review of Common Myelin Disorders
2
Pediatric  Leukoencephalopathies:
  • A Neuroimaging Review of Common Myelin Disorders
3
Introduction

    • The term leukoencephalopathy is broad and encompasses a heterogeneous group of diseases that primarily affect the white matter of the CNS.


    • The disease entities include both primary myelin disorders, axonal/neuronal degeneration and inflammatory disorders.
4
Introduction
  • Leukoencephalopathies are commonly divided into two categories:


    • Dysmyelinating Diseases
      • Also known as leukodystrophies, these disorders result from an inherited defect usually in an enzyme pathway or organelle function, which leads to abnormal formation, destruction, or turnover of myelin.

    • Demyelinating Diseases
      • A group of acquired disorders which result in abnormal destruction of intrinsically normal myelin and/or axons.
5
Learning Objectives
  • MR imaging has emerged as the primary modality for detecting and characterizing white matter disorders.


  • MR findings are often nonspecific. We present a systematic review of the most common features of leukoencephalopathies to help the reader better organize and evaluate these complicated disorders.


  • Diagnosis is ultimately made from a combination of physical, biochemical, and imaging findings.


  • We will begin with a review of the current classification of the leukoencephalopathies.
6
Classification of Leukoencephalopathies




  • Disorders of white matter are divided into heritable enzyme/organelle defects and acquired processes which destroy normal myelin. These categories are further subdivided into:
7
 Heritable Leukodystrophies
    • Lysosomal
      • Metachromatic Leukodystophy (MLD)
      • Krabbe Disease
      • Mucopolysaccharidosis
      • Gangliosidoses GM2
    • Peroxisomal
      • X-linked Adrenoleukodystrophy
      • Zellweger syndrome
    • Mitochondrial
      • MELAS
      • Leigh Disease
      • Kearns-Sayre Syndrome
      • Glutaric Aciduria
      • Alpers Disease
      • Non-Specific Mitochondrial encephalopathy





8
Acquired Demyelinating Diseases
    • Non-infectious/ Non-inflammatory
      • Multiple Sclerosis
        • Neuromyelitis Optica
        •     (Devic disease)

    • Infectious/Inflammatory
      • Acute Disseminated encephalomyelitis (ADEM)
      • Subacute Sclerosing Panencephalitis (SSPE)
      • Progressive Multifocal Leukoencephalopathy
      •    (PML)
      • Subacute HIV infection
      • Viral Encephalitides





9
The Heritable Leukodystrophies
10
Lysosomal Disorders
11
Metachromatic Leukodystrophy (MLD)
  • Inheritance pattern:
    • Autosomal recessive


  • Enzyme defect:
    • Lysosomal Arylsulfatase A
      • This enzyme is necessary for the normal metabolism of sulfatides, a normal constituent of myelin


      • MLD is diagnosed biochemically on the basis of an abnormally low level of arylsulfatase A in peripheral blood leukocytes.


12
Metachromatic Leukodystrophy (MLD)
  • Clinical:
    • 3 forms:
      • late infantile – most common; manifests between 12 and 18 months
      • juvenile
      • adult

    • Characterized by motor signs of peripheral neuropathy including muscle hypotonia, deterioration in intellect, speech and coordination. Vision is impaired due to optic nerve atrophy.


    • Eventually the child becomes blind and completely tetraplegic in a decerebrate state without purposeful movements.


    • Death occurs 6 months to 4 years after symptom onset.




13
Metachromatic Leukodystrophy (MLD)
  • MR imaging features:
    • ↑ T2 signal reported earliest in the corpus callosum, the internal capsules and corticospinal tracts are frequently involved (see figs c & d)


    • T2 high signal is seen more or less symmetrically in the periventricular white matter, in a highly confluent pattern (see figs a & b) with characteristic sparing of the subcortical U-fibers


    • A striped or tigroid appearance of the periventricular white matter is seen (fig b) with central low signal indicating sparing of the perivascular white matter


    • Cerebellar white matter may also be involved


    • Typically no enhancement



14
Krabbe Disease (Globoid Cell Leukodystrophy)
  • Inheritance pattern:
    • Autosomal Recessive


  • Enzyme defect:
    • Lysosomal Galactocerebroside ß-galactosidase
      • This enzyme is necessary in the first step of metabolism of cerebroside, a normal constituent of myelin – cerebrosides accumulate in the lysosomes within white matter, creating the characteristic globoid cells.

15
Krabbe Disease (Globoid Cell Leukodystrophy)
  • Clinical:
    • 4 recognized forms:
      • Infantile – most common; manifests between 1 and 6 months
      • Late infantile
      • Juvenile
      • Adult


    • Initially presents with hyperirritability and periods of fever without other signs of infection.


    • Muscle tone increases with subsequent rapid and severe motor and mental deterioration with constant opisthotonus and hypertonic flexion of the arms and extension of the legs.


    • The disease rapidly progresses with death ensuing between 5 months and 3 years of age.








16
Krabbe Disease (Globoid Cell Leukodystrophy)







  • MR Imaging features
    • ↑T2 seen in the periventricular white matter with sparing of the subcortical
      U-fibers


    • A radiating striped or tigroid appearance is often observed in the white matter, correlating pathologically with perivascular deposits of globoid cells
      (fig b)


    • Posterior limb internal capsule, cerebellar white matter and pyramidal tracts in the brainstem are involved (arrow fig a)


    • With progression of disease, the subcortical white matter becomes involved with generalized atrophy


    • Subtle enhancement is variably seen, usually at the junction between normal and abnormal white matter





17
Mucopolysacchridoses
  • Mucopolysaccharidoses constitute a group of disorders caused by deficiencies of lysosomal enzymes responsible for metabolism of mucopolysaccharides (glycosaminoglycans).


  • Demonstrates ↑ concentration of glycosaminoglycans in the brain and leptomeniges.


  • There are a total of six subdivisions to date which share several clinical features and are subdivided by genetic and biochemical differences.


18
Hurler - Scheie Syndrome (Mucopolysaccharidosis I)
  • Inheritance pattern:
    • Autosomal recessive

  • Enzyme defect
    • Autosomal recessive
    • Deficiency in α-L-ironidase


  • Clinical:
    • 3 subtypes: Hurler, Hurler–Scheie, Scheie (mild)
    • There is considerable clinical variability
    • Normal intelligence to progressive mental retardation, macrocephaly, skeletal abnormalities, hepatosplenomegaly, cardiovascular involvement
    • Patients with Hurler’s demonstrate progressive physical and neurologic deterioration, rarely surviving beyond 16 years of age, while patients with Scheie syndrome may be nearly normal





19
Hurler - Scheie Syndrome (Mucopolysaccharidosis I)

  • MR imaging features:
    • Cystic foci in corpus callosum, basal ganglia and cerebral WM representing enlarged perivascular CSF spaces filled with CSF or mucopolysacchride (arrow fig a)


    • Multifocal ↑ T2 signal in the cerebral WM representing gliosis


    • Ventricular enlargement 2° to hydrocephalus



20
Hunter Syndrome (Mucopolysaccharidosis II)
  • Inheritance pattern:
    • X-linked


  • Enzyme defect:
    • Deficiency in L-sulfoiduronate sulfatase


  • Clinical:
    • Visual disturbances,  progressive deafness, hepatosplenomegaly, cutaneous manifestations




21
Hunter Syndrome (Mucopolysaccharidosis II)
  • MR imaging
    • Scattered ↑ T2 & flair signal predominantly through out the white matter representing gliosis


    • Small punched out cystic lesions in subcortical WM representing enlarged perivascular spaces filled with CSF or mucopolysacchride. (figs a & b)


    • Ventricular enlargement 2° to hydrocephalus


22
Gangliosidoses GM2
  • Inherited disorder of GM2 ganglioside metabolism resulting in neuronal loss and WM degeneration


  • 3 Major subtypes
    • Type AB – Infantile form
    • Type B – Tay-Sachs disease
    • Type O – Sandhoff disease

  • Inheritance pattern:
    • Autosomal recessive

  • Enzyme defect
    • Deficiency in hexosaminidase with abnormal accumulation of GM2 ganglioside in cytoplasm of neurons resulting in neuronal loss WM degenration
    • Dx: assaying hexosaminidase A & B in serum, leukocyte or cultured skin fibroblasts.


23
Gangliosidoses GM2

  • Clinical
    • Similar clinical presentation for Tay-Sachs and Sandhoff
    • Psychomotor retardation and hypotonia, neurologic deterioration in the 1st year of life
    • Progressive motor weakness, spasticity, dystonia, choreaform movements, ataxia, blindness, macrocephaly and seizures
    • Patient becomes bedridden and demented 3 – 10 years
24
Gangliosidoses GM2
  • Tay-Sachs disease
    • MR imaging
      • ↑ T2 thalami, caudate nucleus, globus pallidus and putamen
      • ↑ T1 in globus pallidus, putamen and thalami
      • Diffuse progression of ↑ T2 in the WM



  • Sandhoff disease
    • MR imaging
      • Similar findings to Tay-Sachs with less severity
25
Peroxisomal Disorders
26
X-linked Adrenoleukodystrophy
  • Inheritance pattern:
    • X - linked

  • Enzyme defect:
    • Genetic defect terminal segment of long arm of X chromosome
    • Deficiency of acyl-CoA synthetase
    • Dx by chromosomal assay of plasma, RBC’s or cultured fibroblasts



27
X-linked Adrenoleukodystrophy
  • Clinical:
    • Effects white matter in CNS, adrenal cortex and testes


    • Two major forms
      • Childhood cerebral form
        • Between 5 and 12 yrs
        • Initial presentation of learning difficulties, impaired visual acuity, hearing difficulties, gait disturbance
        • Abnormal skin pigmentation (bronzing), typically predates neurologic abnormalities 2° to adrenal insufficiency
      • Adrenomyeloneuropathy
        • Presents in young adults
        • Incontinence, progressive paraparesis, progressive cerebellar dysfunction


28
X-linked Adrenoleukodystrophy
  • MR features
    • Marked ↑ T2 and ↓ T1 white matter signal abnormalities


    • Posterior predominance, splenium of corpus callosum (80%)


    • Frontal white matter, genu of corpus callosum (15%)


    • Typically spares the U-fibers


    • Enhancement of inflammatory leading edge of demyelination (correlates with worsening clinical status)
29
Mitochondrial Disorders
30
MELAS
(Mitochondrial Encephalopathy with Lactic acidosis and Stroke-Like Episodes)
  • Etiology:
    • Possible deletions of mitochondrial DNA
    • Theory – mitochondrial vasculopathy of small arteries resulting
      in areas of infarct

  • Clinical:
    • Episodes of throbbing headache, nausea, vomiting, permanent or reversible stroke-like events
    • Presentation most commonly 2nd decade, however may present at any age
    • ↑ serum and CSF lactate

31
MELAS
  • MR features:


    • Variable distribution of ↑T2 and flair signal abnormalities that do not follow vascular distribution.


    • Cortex is more severely affected than the underlying WM


    • Cortex enhances after contrast


    • ADC values controversial, studies showing ↑, normal or ↓ values.

32
Glutaric Aciduria Type I
  • Inheritance pattern:
    • Autosomal recessive

  • Enzyme defect:
    • Deficiency of glutaryl-CoA dehydrogenase

  • Clinical:
    • Age of presentation by 12 months
    • Excessive excretion of glutaric acid, glutaconic acid and 3-hydroxy-glutaric acid in the urine
    • Macrocephaly, acute encephalopathy, gradual hypotonia, progressive dystonia, choreoathetosis, tetraplegia

33
Glutaric Aciduria Type I
  • MR features


    • Large CSF spaces over convexities in frontoparietal and frontotemporal regions


    • Prone to developing subdural hemorrhage from stretched bridging veins (ddx. nonaccidental trauma)
      (fig c)


    • Wide sylvian fissures (fig a) due to lack of operculeriztion of the frontal and temporal lobes


    • ↑ T2 in putamen, globus pallidus, caudate head, dentate nucleus, substantia nigra


    • Delayed myelination affecting the frontal and occipital PVWM



34
Leigh Syndrome
  • Subacute necrotizing encephalopathy
    • Neurodegenerative disorder

  • Inheritance pattern:
    • Autosomal recessive (most cases) and X-linked

  • Etiology
    • Inborn error of energy metabolism
    • Defective terminal oxidative metabolism divided into 4 main groups
      • Pyruvate dehydrogenase deficiency complex
      • Complex I deficiency
      • Complex II deficiency
      • Complex IV - Cytochrome oxidase deficiency
      • Complex V – defects in subunit 6 of ATP synthetase

35
Leigh Syndrome
  • Clinical:
    • Variable clinical and pathologic manifestations


    • Multisystem disorder dominated by signs of CNS dysfunction


    • Pathologic abnormalities – microcystic cavitation, vascular proliferation, neuronal loss, demyelination in midbrain, basal ganglia and dentate nuclei and occasional white matter involvement


    • Present typically toward the end of 1st yr of life in infants


    • Hypotonia, psychomotor deterioration, ataxia, ophthalmoplegia, ptosis, dystonia, cranial nerve palsies


    • Causes of death – neurogenic disturbances of respiration, convulsions, coma, hyperpyrexia, cardiac




36
Disorders of Amino Acid & Organic Acid Metabolism
37
Canavan Disease (Spongiform leukodystropy)
  • Inheritance pattern:
    • Autosomal recessive
  • Enzyme defect:
    • Biochemical studies are diagnostic
    • Deficiency in aspartoacylase resulting in ↑ N-acetyl aspartic acid in urine and plasma
    • Accumulation of N-acetylaspartate in oligodendrocytes
  • Clinical:
    • Marked hypotonia with poor head control 1st few wks of life
    • Macrocephaly 2° to ↑ skull growth, psychomotor delay, spasitcity, intellectual failure, cortical blindness and seizures with death by 3 years.


38
Canavan Disease
(Spongiform leukodystropy)
  • MR Imaging features:


    • Subcortical WM affected early and is most severe in the cerebral and cerebellar hemispheres
    • Central WM structures (internl capsule, corpus callosum, periventricular rim WM are preseved)
    • Progressive ↑ T2 and ↓ T1 in the cerebral WM centripetal and confluent in distribution


39
Disorders of Unknown Metabolic Defects
40
Alexander Disease (FIbrinoid Leukodystrophy)
  • Inheritance pattern:
    • Gene mutation for glial fibrillary acidic protiens (GFAP) with accumulation in the cytoplasm resulting in cellular dysfunction


    • Diagnosis strongly suggested with combination of macrocephaly, with clinical and imaging findings along with GFAP gene confirmation


  • 3 forms:
      • Adult
      • Juvenile
      • Neonatal



41
Alexander Disease (FIbrinoid Leukodystrophy)
  • Clinical:
    • Macrocephaly, early onset clinical findings and imaging studies strongly suggest diagnosis, however, biopsy remains the definitive diagnostic tool


    • Accumulation of Rosenthal fibers – hallmark


    • Neonatal form is most severe, rapidly progressive, onset within
      1st month of life, death within 2 yrs of life


    • Juvenile type, symptoms occur between 7 and 14 yrs, progressive bulbar signs and spasticity


    • Adult form, similar clinical presentation to multiple sclerosis
42
Alexander Disease
(Fibrinoid Leukodystrophy)
  • MR Features:


    • ↑ T1 & ↓ T2 periventricular and subcortical WM in frontal lobes, external and extreme capsules


    • ↓ T1 & ↑T2 in caudate head, basal ganglia and hypothalamus


    • Marked T1 hyperintensity periatrial ependymal lining


    • Occipital lobes are spared


43
Pelizaeus-Merzbacher Disease
  • Inheritance pattern:
    • Classic form : X-linked recessive
    • Connatal form : X-linked or autosomal recessive


  • Enzyme defect:
    • Accumulation of proteolipid protein 1 in the endoplasmic reticulum resulting in partly formed myelin molecules

  • Clinical:
    • Abnormal eye movements, nystagmus, extrapyramidal hyperkinesia, spasticity, seizures
    • Death occurs in adolescence to early adulthood in the classic variety and in early childhood for connatal form

44
Pelizaeus-Merzbacher Disease
  • MR imaging features


    • ↑ T2 signal of all unmyelinated white matter extending to the subcortical U fibers, with corresponding ↓ T1 signal changes


    • Some sparing of myelin in parts of the brainstem


    • Progressive white matter atrophy

45
The Acquired Leukoencephalopathies
46
Non-infectious / Non-inflammatory
47
Multiple Sclerosis (MS)
  • Etiology:
    • Presumed autoimmune
    • Idiopathic

  • Facts:
    • First described by Charcot in 1868, MS is the most common demyelinating disease encountered in clinical practice as well as in imaging.

    • Peak age : 30 years with a female predominance
      • (Can also occur in children and adolescents and those over 50 years)


48
Multiple Sclerosis (MS)
  • Clinical:
    • MS is a multiphasic disease with clinical symptoms presenting in 2 or more episodes spaced at least 1 month apart, according to the Schumacher criteria.


    • Clinical presentation in childhood can present subtly as school-related problems and paresthesias, to diffuse encephalopathy with cerebral edema, meningismus and impaired consciousness.


    • MR imaging can supplement the diagnosis by documenting the dissemination of lesions in space and time.



49
Multiple Sclerosis (MS)
  • MR Imaging


    • Imaging findings in children are not significantly different from those in adults.


      • Sharply marginated lesions showing ↓ T1 and ↑ T2 signal in the periventricular white matter, including the corpus callosum.


      • Variable enhancement depending on acuity of the lesion – new lesions enhance for an average of 3 weeks.


      • Spinal cord lesions with associated cord swelling


      • Plaques can show restricted diffusion (fig d, e & f)

    • Tumefactive lesions are more common in children (fig c)



50
Multiple Sclerosis (MS)
  • MR Imaging:
    • Recommended diagnostic criteria for MS in children:
      (at least 3 of the following)


      • One enhancing lesion or nine T2 bright lesions
      • At least one infratentorial lesion  (fig c)
      • At least one juxtacortical lesion
      • At least 3 periventricular lesions (fig b)
      • One spinal cord lesion may be substituted for one brain lesion

    • Enhancement is characteristically limited to one side of the lesion, along the demyelinating edge
      (fig d)


51
Neuromyelitis Optica (NMO)
(Devic disease)
  • A variant of MS, NMO is a syndrome consisting of optic neuritis, often with bilateral total blindness, in combination with transverse myelitis, usually thoracic in location.


  • The optic neuritis and transverse myelitis can occur simultaneously or separated by a brief interval of  several days to several weeks.


  • Age range: 5 to 65 years (but rare over 50 years)


  • No gender predilection


  • More common in the Asian population, where the overall incidence of MS is low


  • Prognosis is poor
    • Until recently 15-20% of patients died in the acute stage due to ascending disease with respiratory arrest
    • Now complete or near complete recovery occurs in roughly 35%




52
Neuromyelitis Optica (NMO)
(Devic disease)
53
Infectious - Inflammatory
54
Acute Demyelinating Encephalomyelitis (ADEM)
  • Etiology:
    • Thought to be an autoimmune response to a CNS antigen triggered by viral infections

  • Facts:
    • An inflammatory/demyelinating process seen more frequently in children, but affects all age groups

    • Typically a monophasic self-limited illness within weeks after:
      • Non-specific respiratory illness
      • Specific viral illness (measles, mumps, rubella, chickenpox, tetanus, flu)
      • Vaccinations (rabies, diptheria, smallpox, tetanus, typhoid)

  • Clinical:
    • fever/headache/mental status changes/meningeal signs/ focal deficits (usually resolve ~ 1 month).


55
Acute Demyelinating Encephalomyelitis (ADEM)
  • MR Features:
    • Virtually identical to MS  (mass-like with no mass effect)


    • T2 bright lesions:
      • Supratentorial white matter (fig a)
      • Brainstem (fig b)
      • Cerebellum
      • Deep white matter (fig c)
      • Optic Neuritis
      • Spinal cord involvement


    • Lesions can enhance and show restricted diffusion
      (fig d arrow)
56
Subacute Sclerosing Panencephalitis (SSPE)
  • Etiology:
    • A chronic measles virus infection which causes apoptosis of neurons, oligodendrocytes & lymphocytes.
    • Although a rare disorder, it is the commonest of the chronic viral infections to affect children.

  • Facts:
    • Age range: 4 – 25 years;  peak at 9 years;  rare in adults
    • Children who acquire measles under 1 year of age are more likely to develop SSPE.


  • Clinical:
    • Can be quite variable and range from 3 months to 7 years, usually with 4 discernable stages:
      • Stage 1: insidious intellectual & behavioral deterioration, slurred speech, vision changes
      • Stage 2: Myoclonia of all somatic muscles, convulsions, choreoathetosis, tremor & spasticity
      • Stage 3: Severe dementia, frequent extrapyramidal dysfunction, myoclonia diminishes
      • Stage 4: Child is in a vegetative state characterized by mutism and decerebrate or decorticate posture


57
Subacute Sclerosing Panencephalitis (SSPE)
  • MR Features:
  • Abnormal signal can be seen:
    • Focal:
      • Basal Ganglia
      • Lateral geniculate bodies
    • Diffuse:
      • Subcortical white matter (WM)
      • Deep & periventricular WM

  • The overlying cortex is often affected  (fig a)


  • Bilateral striatal lesions, brain stem lesion, and cerebellar peduncle lesions are also seen.


  • End-stage disease shows diffuse atrophy







58
Progressive Multifocal Leukoencephalopathy (PML)
  • Etiology:
    • PML is a rare demyelinating infection of the CNS by the JC polyomavirus virus -- a papovavirus


  • Facts:
    • Predominantly occurs in immunodeficient patients, and in recent years has been seen most commonly in the context of AIDS.
      Also seen in association with:
      • Lymphoma/ SLE/ renal transplantation/ Multiple Myeloma/ Sarcoid/ TB/ Whipple disease

  • Predominantly seen in adults, but has been described in children with similar imaging findings.
59
Progressive Multifocal Leukoencephalopathy (PML)
  • Clinical:
    • Typical early presentation includes cognitive impairment, sometimes with personality changes.


    • Monoparesis, hemparesis, dysarthria, ataxia, sensory impairments and visual loss ensue.


    • Quadriparesis, severe dementia and coma are seen in advanced stages of the disease.


    • Once the disease appears it typically progresses until the patient dies.
60
Progressive Multifocal Leukoencephalopathy (PML)
  • MR Features:
    • Lesion with ↑ T2 signal can be found anywhere in the cerebral or cerebellar WM and the brainstem


    • Most commonly involves the  frontal and parieto-occipital subcortical WM; but can involve basal ganglia and thalami (fig a)


    • Subcortical lesions form a scalloped appearance where they border the overlying gray matter.


    • Confluence of multiple lesions give rise to the appearance of wide spread white matter disease


    • Enhancement is seen in a minority of cases
61
Acute Necrotizing Encephalitis
  • An acute encephalopathy with thalamotegmental involvement


  • Most likely immune-mediated or metabolic
    • Influenza A and B viruses and human herpes virus have been implicated


  • Clinical:
    • Infants between 6 to 18 months
    • History of mild antecendent illness (90%) ~ 3 days followed by acute onset of convulsions, impaired conscoiousness, vomiting, coma in
      24 hrs
    • Biochemical analysis shows
      • ↑ aspartate amino-transferase (82%)
      • ↑ alanine aminotransferase (70%)
      • ↑ lactate dehydrogenase (77%)


62
Acute Necrotizing Encephalitis
  • MR imaging features
    • Bilateral thalamic involvement with ↑ T2 and ↓ T1 signal


    • Confluent lesions involving lateral putamina and external and extreme capsules


    • These lesions become hemorrhagic and cavitate centrally


    • Calcifications can be seen in the basal ganglia



63
Toxic - Metabolic
64
Posterior Reversible Encephalopathy Syndrome (PRES)
  • Hypertensive episodes lead to transient clinical symptoms such as headache, nausea, vomiting, altered mentation and seizures.


  • The MR findings can be associated with the following disease entities:
    • Pre-eclampsia/ Eclampsia
    • Renal insufficiency
    • Hemolytic-uremic syndrome
    • Thrombotic thrombocytopenic purpura
    • Patients undergoing chemotherapy/ immunosuppressive therapy and bone marrow or solid organ transplantation


  • Presumed etiologies:
    • Immunological maternal reaction (in eclampsia)
    • Dietary factors
    • Genetic factors






65
Posterior Reversible Encephalopathy Syndrome (PRES)
  • MR Features:
    • ↑ T2 and ↓ T1 signal predominantly affecting the parieto-occipital regions symmetrically


    • Involves white matter as well as cortex


    • May solely affect the thalami, frontal border zones, midbrain, pons or cerebellum


    • Initial period may have associated mass effect and hydrocephalus


    • Some lesions may progress to infarction and DWI must be utilized


    • With treatment lesions disappear completely or nearly completely


66
Post-chemotherapy Leukoencephalopathy
  • Abnormalities in the white matter 2° chemotherapy agents


  • Most common offending agents
    • Methotrexate, Cisplatin, Arabinosylcytosine, Carmustine, Thiopeta

  • WM abnormalities may be transient or permanent,
    with or without associated clinical abnormalities


  • Clinical:
    • Neurologic symptoms occur with acute injury



67
Post – Chemotherapy Leukoencephalopathy
  • MR imaging features


    • Symmetric ↑ T2, ↓ T1 abnormalities


    • Central and periventricular WM, can be wide spread and diffuse


    • Relative sparing of U-fibers


    • Diffusion imaging shows reduced diffusion in affected areas (figs c & d)
68
In Summary
  • Pediatric leukoencephalopathies comprise a broad group of disease entities many of which may have non-specific MR imaging characteristics which overlap one another


  • Certain imaging findings, however, are characteristic and were highlighted in this presentation


  • We’ve found that a systematic approach, using a well-described classification system, along with imaging, clinical and biochemical data, helps to narrow the differential
69
References
  • Van der Knaap MS, Jaap V. Magnetic Resonance of Myelination and Myelin Disorders. Third edition. Springer-Verlag Berlin Heidelberg, 2005.
  • Barkovich JA. Pediatric Neuroimaging. Fourth edition. Lippincott Williams & Wilkins, 2005.
  • Cheon JE et al. Leukodystrophy in Children: A Pictorial Review of MR Imaging Features. Radiographics 2002;22:461-476.
  • Suzuki K, Armao D, Stone JA, Mukherji SK. Demyelinating Diseases, Leukodystrophies, and Other Myelin Disorders. Neuroimaging Clin  N Am 2001;11(1):15-35.
  • Osborn. Diagnostic Imaging Brain. First Edition. Amirsys Inc 2004.